All age groups in the US are consuming more than twice the daily recommended amount of sugar and almost 10% of Americans have diabetes(1). Inulox aims to provide a novel solution to the ‘sugar problem’.
We are five students at the University of Oxford currently pursuing doctoral studies in diverse bioscience research areas. Our scientific backgrounds and expertise cover a breadth of fields including drug discovery, biotechnology, chemistry and bioprocess engineering.
The foundational expertise of Inulox was nurtured by working alongside world-leading researchers at elite universities and various start-up companies. As a highly enthusiastic and dynamic team, we are keen to develop products that promote gastrointestinal health and tackle diet-related diseases.